U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from BioSystems

Items: 11

1.
Overcoming Resistance to Endocrine Therapy in Breast Cancer: New Approaches to a Nagging Problem
Yunus A. Luqmani, Nada Alam-Eldin
Med Princ Pract. 2016 Jul; 25(Suppl 2): 28–40. Published online 2016 Feb 5. doi: 10.1159/000444451
PMCID:
PMC5588530
ArticlePDF–280K
2.
ESR1 mutations as a mechanism for acquired endocrine resistance in breast cancer
Rinath Jeselsohn, Gilles Buchwalter, Carmine De Angelis, Myles Brown, Rachel Schiff
Nat Rev Clin Oncol. Author manuscript; available in PMC 2016 Jun 16.
Published in final edited form as: Nat Rev Clin Oncol. 2015 Oct; 12(10): 573–583. Published online 2015 Jun 30. doi: 10.1038/nrclinonc.2015.117
PMCID:
PMC4911210
ArticlePDF–685K
3.
The Role of MicroRNAs as Predictors of Response to Tamoxifen Treatment in Breast Cancer Patients
Nina G. Egeland, Siri Lunde, Kristin Jonsdottir, Tone H. Lende, Deirdre Cronin-Fenton, Bjørnar Gilje, Emiel A. M. Janssen, Håvard Søiland
Int J Mol Sci. 2015 Oct; 16(10): 24243–24275. Published online 2015 Oct 14. doi: 10.3390/ijms161024243
PMCID:
PMC4632748
ArticlePDF–2.6M
4.
Estrogen signaling crosstalk: implications for endocrine resistance in ovarian cancer
Jennifer R. Ribeiro, Richard N. Freiman
J Steroid Biochem Mol Biol. Author manuscript; available in PMC 2015 Sep 1.
Published in final edited form as: J Steroid Biochem Mol Biol. 2014 Sep; 0: 160–173. Published online 2014 Feb 22. doi: 10.1016/j.jsbmb.2014.02.010
PMCID:
PMC4127339
ArticlePDF–790K
5.
GPR30 as an initiator of tamoxifen resistance in hormone-dependent breast cancer
Zhiqiang Mo, Manran Liu, Fangfang Yang, Haojun Luo, Zhenhua Li, Gang Tu, Guanglun Yang
Breast Cancer Res. 2013; 15(6): R114. Published online 2013 Nov 29. doi: 10.1186/bcr3581
PMCID:
PMC3978564
ArticlePDF–3.2M
6.
Endocrine Resistance in Breast Cancer: Focus on the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Pathway
Shira Peleg Hasson, Tami Rubinek, Larysa Ryvo, Ido Wolf
Breast Care (Basel) 2013 Aug; 8(4): 248–255. Published online 2013 Aug 20. doi: 10.1159/000354757
PMCID:
PMC3808218
ArticlePDF–232K
7.
Tamoxifen Resistance in Breast Cancer
Minsun Chang
Biomol Ther (Seoul) 2012 May; 20(3): 256–267. doi: 10.4062/biomolther.2012.20.3.256
PMCID:
PMC3794521
ArticlePDF–546K
8.
Aromatase inhibition 2013: clinical state of the art and questions that remain to be solved
Per Eystein Lønning, Hans Petter Eikesdal
Endocr Relat Cancer. 2013 Aug; 20(4): R183–R201. Prepublished online 2013 Apr 26. doi: 10.1530/ERC-13-0099
PMCID:
PMC3689263
ArticlePDF–419K
9.
MECHANISMS OF ENDOCRINE RESISTANCE IN BREAST CANCER
C Kent Osborne, Rachel Schiff
Annu Rev Med. Author manuscript; available in PMC 2013 May 17.
Published in final edited form as: Annu Rev Med. 2011; 62: 233–247. doi: 10.1146/annurev-med-070909-182917
PMCID:
PMC3656649
ArticlePDF–661K
10.
Endocrine resistance in breast cancer: From cellular signaling pathways to epigenetic mechanisms
Stéphanie Bianco, Nicolas Gévry
Transcription. 2012 Jul 1; 3(4): 165–170. doi: 10.4161/trns.20496
PMCID:
PMC3654764
ArticlePDF–837K
11.
Mechanisms of Resistance to Endocrine Therapy in Breast Cancer: Focus on Signaling Pathways, miRNAs and Genetically Based Resistance
Rocío García-Becerra, Nancy Santos, Lorenza Díaz, Javier Camacho
Int J Mol Sci. 2013 Jan; 14(1): 108–145. Published online 2012 Dec 20. doi: 10.3390/ijms14010108
PMCID:
PMC3565254
ArticlePDF–973K

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

You are here: NCBI > Literature > PubMed Central (PMC)
Support Center